Human Health and Potential (HHP)

A new sequencing technique called PORE-cupine combines artificial intelligence to reveal ribonucleic acid structures in cells.

A new biomarker in liver tumor may help doctors predict how patients respond to immunotherapy.

The discovery of how aging impacts memory T cells may unlock novel therapeutic targets to boost immune protection in older adults.

A genetic cause for anencephaly, a common neural tube defect found in developing fetuses, has been identified for the first time.

Horizontal Technology Programme Offices will bring A*STAR’s deep capabilities to bear on real-world issues facing Singapore and the wider world, says Deputy Chief Executive (Research), Andy Hor.

Understanding the impact of antibiotics on both infants and adults could help restore the delicate balance of the gut microbiome.

A*STAR is poised to contribute towards Singapore’s Research, Innovation and Enterprise 2025 plan across all four strategic domains.

Fasting during the month of Ramadan has limited benefits for weight loss, finds an A*STAR review.

Being able to distinguish between different types of macrophages in the brain could shed light on inflammatory diseases such as Alzheimer’s.

The Epstein-Barr virus can cause epigenetic changes that persist even after the infection has been cleared, highlighting why prevention is better than cure when it comes to gastric cancer.

Keratin, a tough and insoluble fibrous protein, plays a surprising role in determining mouse embryonic cell fate.

Three A*STAR scholars—Sarah Luo, Caroline Wee, and Kaicheng Liang—have been selected for the highly competitive National Research Foundation Fellowship out of over 134 applicants worldwide.